Eyestem Research has announced that it has submitted an Investigational New Drug (IND) application to the Central Drugs Standards Control Organisation, India (CDSCO) to begin the first in-human trials of Eyecyte-RPE for subjects with medium- to...
Dr Reddy's Laboratories Ltd announced that its DRL_TC tocilizumab biosimilar candidate met primary and secondary endpoints in a Phase I study. This Phase I study compared the pharmacokinetic equivalence, safety, and immunogenicity of Dr. Reddy's ...
Coherus BioSciences Inc said last week it plans to launch a biosimilar of AbbVie Inc's Humira in July at a list price of $995 per carton, representing a discount of about 85 per cent from the bzlockbuster arthritis drug...
Hyderabad, known as India's pharma hub, is home to 214 USFDA-approved facilities, and as the pharma market grows due to complex molecules, companies will be forced to invest in and build future state-of-the-art labs, according to a Dr Reddy's...
Anil Khubchandani has been appointed as managing director and CEO of Sekhmet Pharmaventures Pvt Ltd, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies, by a private...
AstraZeneca, a British-Swedish pharmaceutical company, announced this week that its anti-liver cancer drug tremelimumab combination has been approved by India's drug regulator...
